These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23728171)

  • 61. Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization.
    Kárpáti É; Papp A; Schneider AE; Hajnal D; Cserhalmi M; Csincsi ÁI; Uzonyi B; Józsi M
    Front Immunol; 2020; 11():1297. PubMed ID: 32765490
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2019; 10():853. PubMed ID: 31118930
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies.
    Irmscher S; Brix SR; Zipfel SLH; Halder LD; Mutlutürk S; Wulf S; Girdauskas E; Reichenspurner H; Stahl RAK; Jungnickel B; Wiech T; Zipfel PF; Skerka C
    Nat Commun; 2019 Jul; 10(1):2961. PubMed ID: 31273197
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human complement factor H: an additional gene product of 43 kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement.
    Misasi R; Huemer HP; Schwaeble W; Sölder E; Larcher C; Dierich MP
    Eur J Immunol; 1989 Sep; 19(9):1765-8. PubMed ID: 2529127
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of membrane phospholipids on activation of the alternative complement pathway.
    Mold C
    J Immunol; 1989 Sep; 143(5):1663-8. PubMed ID: 2527270
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of interferon-gamma on complement gene expression in different cell types.
    Lappin DF; Guc D; Hill A; McShane T; Whaley K
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):437-42. PubMed ID: 1531292
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.
    Vernon KA; Ruseva MM; Cook HT; Botto M; Malik TH; Pickering MC
    J Am Soc Nephrol; 2016 May; 27(5):1334-42. PubMed ID: 26374608
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.
    Dragon-Durey MA; Blanc C; Marliot F; Loirat C; Blouin J; Sautes-Fridman C; Fridman WH; Frémeaux-Bacchi V
    J Med Genet; 2009 Jul; 46(7):447-50. PubMed ID: 19435718
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation.
    Heinen S; Hartmann A; Lauer N; Wiehl U; Dahse HM; Schirmer S; Gropp K; Enghardt T; Wallich R; Hälbich S; Mihlan M; Schlötzer-Schrehardt U; Zipfel PF; Skerka C
    Blood; 2009 Sep; 114(12):2439-47. PubMed ID: 19528535
    [TBL] [Abstract][Full Text] [Related]  

  • 71. C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.
    Zhang Y; Keenan A; Dai DF; May KS; Anderson EE; Lindorfer MA; Henrich JB; Pitcher GR; Taylor RP; Smith RJ
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32376801
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Complement system regulation and C3 glomerulopathy].
    Xiao HJ; He RJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):323-6. PubMed ID: 23591359
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Control of serum C3 levels by beta 1H and C3b inactivator.
    Wyatt RJ; Forristal J; Davis CA; Coleman TH; West CD
    J Lab Clin Med; 1980 Jun; 95(6):905-17. PubMed ID: 6445926
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Autoantibodies Against C3b-Functional Consequences and Disease Relevance.
    Vasilev VV; Radanova M; Lazarov VJ; Dragon-Durey MA; Fremeaux-Bacchi V; Roumenina LT
    Front Immunol; 2019; 10():64. PubMed ID: 30761135
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Alternative complement pathway].
    Jouvin MH; Kazatchkine M
    Sem Hop; 1984 May; 60(19):1371-8. PubMed ID: 6326330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Pangburn MK; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2416-20. PubMed ID: 276881
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement.
    Kew RR; Ghebrehiwet B; Janoff A
    J Clin Invest; 1985 Mar; 75(3):1000-7. PubMed ID: 3156879
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
    McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
    J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment.
    Medjeral-Thomas NR; Moffitt H; Lomax-Browne HJ; Constantinou N; Cairns T; Cook HT; Pickering MC
    Kidney Int Rep; 2019 Oct; 4(10):1387-1400. PubMed ID: 31701048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.